Overview

Neoadjuvant Chemotherapy for Resectable Cancer of the Pancreatic Head

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
Neodajuvant chemotherapy with gemcitabine / cisplatin is applied to patients with resectable cancer of pancreatic head.
Phase:
Phase 2
Details
Lead Sponsor:
University of Zurich
Treatments:
Cisplatin
Gemcitabine